Yolanda Hagar

Yolanda Hagar

University of Colorado Boulder

H-index: 17

North America-United States

About Yolanda Hagar

Yolanda Hagar, With an exceptional h-index of 17 and a recent h-index of 14 (since 2020), a distinguished researcher at University of Colorado Boulder, specializes in the field of Statistics, Biostatistics.

His recent articles reflect a diverse array of research interests and contributions to the field:

ASSESSING THE CLINICAL UTILITY OF A PROTEOMICS-BASED CARDIOVASCULAR RISK TEST TO GUIDE RISK-CONCORDANT TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Cardiovascular Event Risk Prediction

Re‐calibration and performance of a proteomic prognostic test for 5‐year dementia risk

Using the Proteome to Detect Biomarkers of Cardiovascular Comorbidities

Statin Signature: Using Proteomics to Detect Pharmacological Fingerprints

Efficient development of prognostic tests for detecting cancer risk using proteomic technology

Methods of Determining Impaired Glucose Tolerance

Development and validation of a blood‐based protein predictor of 20‐year dementia risk from middle age

Yolanda Hagar Information

University

Position

Applied Mathematics Department

Citations(all)

1559

Citations(since 2020)

1018

Cited By

921

hIndex(all)

17

hIndex(since 2020)

14

i10Index(all)

22

i10Index(since 2020)

17

Email

University Profile Page

Google Scholar

Yolanda Hagar Skills & Research Interests

Statistics

Biostatistics

Top articles of Yolanda Hagar

ASSESSING THE CLINICAL UTILITY OF A PROTEOMICS-BASED CARDIOVASCULAR RISK TEST TO GUIDE RISK-CONCORDANT TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Journal of the American College of Cardiology

2024/4/2

Cardiovascular Event Risk Prediction

2023/12/7

Re‐calibration and performance of a proteomic prognostic test for 5‐year dementia risk

Alzheimer's & Dementia

2023/12

Using the Proteome to Detect Biomarkers of Cardiovascular Comorbidities

Circulation

2023/11/7

Yolanda Hagar
Yolanda Hagar

H-Index: 14

Statin Signature: Using Proteomics to Detect Pharmacological Fingerprints

Circulation

2023/11/7

Efficient development of prognostic tests for detecting cancer risk using proteomic technology

Cancer Research

2023/4/4

Methods of Determining Impaired Glucose Tolerance

2023/2/16

Development and validation of a blood‐based protein predictor of 20‐year dementia risk from middle age

Alzheimer's & Dementia

2022/12

PROCEDURE FOR DETERMINING DISEASE RISK USING A COMBINATION OF DOWNSAMPLING OF CLASS IMBALANCED DATASETS WITH SURVIVAL ANALYSIS

2022/8/24

Development and validation of a blood-based protein-only predictor of 5-year lung cancer risk in ever smokers

Cancer Research

2022/6/15

Clare Paterson
Clare Paterson

H-Index: 6

Yolanda Hagar
Yolanda Hagar

H-Index: 14

A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk

Science translational medicine

2022/4/6

Methods For Determining Disease Risk Combining Downsampling of Class-Imbalanced Sets With Survival Analysis

2022/1/20

Health impacts of a randomized biomass cookstove intervention in northern Ghana

BMC Public Health

2021/12

Progress Towards a Proteomic Surrogate Endpoint for Cardiovascular Outcomes

Circulation

2021/11/16

Application of a 27-protein candidate cardiovascular surrogate endpoint to track risk ascendancy and resolution in COVID-19

medRxiv

2021/2/1

PLASMA PROTEIN SCANNING AS A NEW TOOL IN PREVENTIVE CARDIOLOGY

Journal of the American College of Cardiology

2020/3/24

Plasma protein patterns as comprehensive indicators of health

2020

See List of Professors in Yolanda Hagar University(University of Colorado Boulder)